{"id":"https://openalex.org/W2009016493","doi":"https://doi.org/10.1016/j.anaerobe.2009.09.005","title":"Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection","display_name":"Typing and susceptibility of bacterial isolates from the fidaxomicin (OPT-80) phase II study for C. difficile infection","publication_year":2009,"publication_date":"2009-09-13","ids":{"openalex":"https://openalex.org/W2009016493","doi":"https://doi.org/10.1016/j.anaerobe.2009.09.005","mag":"2009016493","pmid":"https://pubmed.ncbi.nlm.nih.gov/19755166"},"language":"en","primary_location":{"id":"doi:10.1016/j.anaerobe.2009.09.005","doi":"https://doi.org/10.1016/j.anaerobe.2009.09.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.anaerobe.2009.09.005","pdf_url":null,"source":{"id":"https://openalex.org/S187465954","display_name":"Anaerobe","issn_l":"1075-9964","issn":["1075-9964","1095-8274"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anaerobe","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053319026","display_name":"Diane M. Citron","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.M. Citron","raw_affiliation_strings":["RM Alden Research Lab, Culver City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RM Alden Research Lab, Culver City, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006964684","display_name":"Farah Babakhani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Babakhani","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., 10110 Sorrento Valley Road Ste. San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., 10110 Sorrento Valley Road Ste. San Diego, CA 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062693388","display_name":"Ellie J. C. Goldstein","orcid":"https://orcid.org/0000-0002-1044-6159","observed_orcids":["https://orcid.org/0000-0002-1044-6159"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E.J.C. Goldstein","raw_affiliation_strings":["RM Alden Research Lab, Culver City, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RM Alden Research Lab, Culver City, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038365293","display_name":"Kristin J. Nagaro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802230104","display_name":"Edward Hines, Jr. VA Hospital","ror":"https://ror.org/02223wv31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2802230104","https://openalex.org/I4210115976"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Nagaro","raw_affiliation_strings":["Edward Hines Jr. Veterans Affairs Hospital, Hines, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Edward Hines Jr. Veterans Affairs Hospital, Hines, IL, USA","institution_ids":["https://openalex.org/I2802230104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083170826","display_name":"Susan P. Sambol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802230104","display_name":"Edward Hines, Jr. VA Hospital","ror":"https://ror.org/02223wv31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2802230104","https://openalex.org/I4210115976"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Sambol","raw_affiliation_strings":["Edward Hines Jr. Veterans Affairs Hospital, Hines, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Edward Hines Jr. Veterans Affairs Hospital, Hines, IL, USA","institution_ids":["https://openalex.org/I2802230104"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113001519","display_name":"P.S. Sears","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"P. Sears","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., 10110 Sorrento Valley Road Ste. San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., 10110 Sorrento Valley Road Ste. San Diego, CA 92121, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110102391","display_name":"Youe\u2010Kong Shue","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y.-K. Shue","raw_affiliation_strings":["Optimer Pharmaceuticals, Inc., 10110 Sorrento Valley Road Ste. San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optimer Pharmaceuticals, Inc., 10110 Sorrento Valley Road Ste. San Diego, CA 92121, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002008542","display_name":"Dale N. Gerding","orcid":"https://orcid.org/0000-0003-4409-1605","observed_orcids":["https://orcid.org/0000-0003-4409-1605"]},"institutions":[{"id":"https://openalex.org/I1925986","display_name":"Loyola University Chicago","ror":"https://ror.org/04b6x2g63","country_code":"US","type":"education","lineage":["https://openalex.org/I1925986"]},{"id":"https://openalex.org/I2802230104","display_name":"Edward Hines, Jr. VA Hospital","ror":"https://ror.org/02223wv31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2802230104","https://openalex.org/I4210115976"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.N. Gerding","raw_affiliation_strings":["Edward Hines Jr. Veterans Affairs Hospital, Hines, IL, USA","Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Edward Hines Jr. Veterans Affairs Hospital, Hines, IL, USA","institution_ids":["https://openalex.org/I2802230104"]},{"raw_affiliation_string":"Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA","institution_ids":["https://openalex.org/I1925986"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5113001519"],"corresponding_institution_ids":[],"apc_list":{"value":3350,"currency":"USD","value_usd":3350},"apc_paid":null,"fwci":6.1814,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.96340922,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"15","issue":"6","first_page":"234","last_page":"236"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clostridium-difficile-infection","display_name":"Clostridium difficile infection","score":0.9940000176429749},{"id":"https://openalex.org/keywords/fidaxomicin","display_name":"fidaxomicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ribotype-027","display_name":"ribotype 027","score":0.7749999761581421},{"id":"https://openalex.org/keywords/antibiotic-susceptibility","display_name":"antibiotic susceptibility","score":0.671999990940094},{"id":"https://openalex.org/keywords/metronidazole","display_name":"metronidazole","score":0.8759999871253967},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/restriction-endonuclease-analysis","display_name":"restriction endonuclease analysis","score":0.8679999709129333},{"id":"https://openalex.org/keywords/clinical-cure","display_name":"clinical cure","score":0.4959999918937683}],"concepts":[{"id":"https://openalex.org/C2781342628","wikidata":"https://www.wikidata.org/wiki/Q5446672","display_name":"Fidaxomicin","level":5,"score":0.8579708933830261},{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.8283912539482117},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.8025703430175781},{"id":"https://openalex.org/C2777396551","wikidata":"https://www.wikidata.org/wiki/Q169569","display_name":"Metronidazole","level":3,"score":0.7529922723770142},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.7373543977737427},{"id":"https://openalex.org/C2780493024","wikidata":"https://www.wikidata.org/wiki/Q19903202","display_name":"Agar dilution","level":4,"score":0.6141470074653625},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.553667426109314},{"id":"https://openalex.org/C2776490000","wikidata":"https://www.wikidata.org/wiki/Q2548046","display_name":"Chocolate agar","level":4,"score":0.4283994436264038},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4277842044830322},{"id":"https://openalex.org/C2778660310","wikidata":"https://www.wikidata.org/wiki/Q177998","display_name":"Agar","level":3,"score":0.33312559127807617},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3179033696651459},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.24630951881408691},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.1591927409172058},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.054383933544158936},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000091402","descriptor_name":"Prohibitins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004262","descriptor_name":"DNA Restriction Enzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004761","descriptor_name":"Enterocolitis, Pseudomembranous","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004761","descriptor_name":"Enterocolitis, Pseudomembranous","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D004761","descriptor_name":"Enterocolitis, Pseudomembranous","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005243","descriptor_name":"Feces","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006027","descriptor_name":"Glycosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015373","descriptor_name":"Bacterial Typing Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016360","descriptor_name":"Clostridioides difficile","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021521","descriptor_name":"Ribotyping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.anaerobe.2009.09.005","doi":"https://doi.org/10.1016/j.anaerobe.2009.09.005","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.anaerobe.2009.09.005","pdf_url":null,"source":{"id":"https://openalex.org/S187465954","display_name":"Anaerobe","issn_l":"1075-9964","issn":["1075-9964","1095-8274"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anaerobe","raw_type":"journal-article"},{"id":"pmid:19755166","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19755166","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anaerobe","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2419550889","display_name":"New Treatment for C. difficile-Associated Diarrhea","funder_award_id":"R44AI063692","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W140595635","https://openalex.org/W1531222087","https://openalex.org/W2044370864","https://openalex.org/W2065777365","https://openalex.org/W2084193745","https://openalex.org/W2101233913","https://openalex.org/W2104518766","https://openalex.org/W2113721855","https://openalex.org/W2135164316","https://openalex.org/W2138430214","https://openalex.org/W2139754977","https://openalex.org/W2147511770","https://openalex.org/W2150765371","https://openalex.org/W2156891220","https://openalex.org/W2163423623","https://openalex.org/W2166223093","https://openalex.org/W2292857696","https://openalex.org/W2398336976","https://openalex.org/W4236988366","https://openalex.org/W6605749227"],"related_works":["https://openalex.org/W4232767873","https://openalex.org/W2098455823","https://openalex.org/W2153534612","https://openalex.org/W7096187947","https://openalex.org/W1906018090","https://openalex.org/W7095528237","https://openalex.org/W2333195366","https://openalex.org/W4408141353","https://openalex.org/W2170009866","https://openalex.org/W2106310075"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":13}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}